Clinical trial
National Transfusion Treatment Survey in Patients With Sickle Cell Disease (SCD)
NCT03397017 is registered in ClinicalTrials.gov with Società Italiana Talassemie ed Emoglobinopatie as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- National Transfusion Treatment Survey in Patients With Sickle Cell Disease (SCD)
- Lead sponsor
- Società Italiana Talassemie ed Emoglobinopatie
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 1, 2016
- Completion date
- June 30, 2022
- Enrollment
- 200 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.